A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays (Q59650911)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11792386%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

title

A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11792386%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

0 references

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11792386%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Deborah L Birx

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11792386%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Josephine H Cox

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11792386%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Jeffrey R Currier

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11792386%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Ellen G Kuta

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11792386%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Ellen Turk

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11792386%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Lyndsay B Earhart

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11792386%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Larry Loomis-Price

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11792386%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Sylvia Janetzki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11792386%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

publication date

1 February 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11792386%20AND%20SRC:MED&resulttype=core&format=json

Journal of Immunological Methods

6 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11792386%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

volume

260

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11792386%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11792386%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

page(s)

157-172

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11792386%20AND%20SRC:MED&resulttype=core&format=json

Field studies of cytotoxic T lymphocytes in malaria infections: implications for malaria vaccine development

6 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900535-X

HLA Class I nucleotide sequences, 1995

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900535-X

Putative immunodominant human immunodeficiency virus-specific CD8(+) T-cell responses cannot be predicted by major histocompatibility complex class I haplotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900535-X

Efficacy testing of recombinant human immunodeficiency virus (HIV) gp160 as a therapeutic vaccine in early-stage HIV-1-infected volunteers. rgp160 Phase II Vaccine Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900535-X

Conservation of T cell receptor usage by HLA B27-restricted influenza-specific cytotoxic T lymphocytes suggests a general pattern for antigen-specific major histocompatibility complex class I-restricted responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900535-X

Vaccination of seronegative volunteers with a human immunodeficiency virus type 1 env/rev DNA vaccine induces antigen-specific proliferation and lymphocyte production of beta-chemokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900535-X

CD8 independence and specificity of cytotoxic T lymphocytes restricted by HLA-Aw68. 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900535-X

HLA-A, -B, -DRB1, -DQA1, and -DQB1 polymorphism in Thais

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900535-X

AIDS vaccine shows promise after years of frustration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900535-X

Reverse ELISPOT assay for clonal analysis of cytokine production I. Enumeration of gamma-interferon-secreting cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900535-X

HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900535-X

Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900535-X

Multiepitopic B- and T-cell responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900535-X

Differential narrow focusing of immunodominant human immunodeficiency virus gag-specific cytotoxic T-lymphocyte responses in infected African and caucasoid adults and children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900535-X

Rapid definition of five novel HLA-A*3002-restricted human immunodeficiency virus-specific cytotoxic T-lymphocyte epitopes by elispot and intracellular cytokine staining assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900535-X

Phenotype and frequency of cells secreting IL-2, IL-4, IL-6, IL-10, IFN and TNF-alpha in human peripheral blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900535-X

Direct visualization of cytokine-producing recall antigen-specific CD4 memory T cells in healthy individuals and HIV patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900535-X

Detection and quantification of blood-derived CD8+ T lymphocytes secreting tumor necrosis factor alpha in response to HLA-A2.1-binding melanoma and viral peptide antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900535-X

Immunization of cancer patients with autologous cancer-derived heat shock protein gp96 preparations: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900535-X

Polymorphisms in HLA class I genes associated with both favorable prognosis of human immunodeficiency virus (HIV) type 1 infection and positive cytotoxic T-lymphocyte responses to ALVAC-HIV recombinant canarypox vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900535-X

CD8(+) lymphocytes respond to different HIV epitopes in seronegative and infected subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900535-X

Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900535-X

Rapid effector function in CD8+ memory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900535-X

A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900535-X

Evaluation of CD8(+) T-cell frequencies by the Elispot assay in healthy individuals and in patients with metastatic melanoma immunized with tyrosinase peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900535-X

Major histocompatibility complex genotype is associated with disease progression and virus load levels in a cohort of human immunodeficiency virus type 1-infected Caucasians and African Americans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900535-X

A sensitive ELISPOT assay to detect low-frequency human T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900535-X

HIV type 1 vaccine-induced cytotoxic T cell responses in phase I clinical trials: detection, characterization, and quantitation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900535-X

Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900535-X

Cellular immune responses to HIV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900535-X

HIV-1-Specific CD4 helper function in persons with chronic HIV-1 infection on antiviral drug therapy as measured by ELISPOT after treatment with an inactivated, gp120-depleted HIV-1 in incomplete Freund's adjuvant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900535-X

Challenges and opportunities for development of an AIDS vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900535-X

Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900535-X

Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900535-X

Quantitation of antigen-reactive T cells in peripheral blood by IFNgamma-ELISPOT assay and chromium-release assay: a four-centre comparative trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900535-X

Quantification of tumor-specific T lymphocytes with the ELISPOT assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900535-X

Immunologic monitoring of clinical trials in patients with cancer: technology versus common sense

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900535-X

10.1016/S0022-1759(01)00535-X

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11792386%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11792386%20AND%20SRC:MED&resulttype=core&format=json